Clinical Trial Update: Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update evaluating azacitidine in combination with QPOP and CURATE.AI for solid tumors is currently recruiting, covering solid tumors,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastrointestinal Cancer
• Solid Tumors

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Solid Tumor, Gastrointestinal Cancer | Phase 1, Phase 2 | Status: RECRUITING